CRNX – crinetics pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $65.00 price target on the stock.
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Investors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen solid returns of 196% over the past three years [Yahoo! Finance]
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Form 4 Crinetics Pharmaceutical For: May 10 Filed by: Betz Stephen F.
Form 4 Crinetics Pharmaceutical For: May 08 Filed by: Struthers Richard Scott
Form 144 Crinetics Pharmaceutical Filed by: Betz Stephen F.
Form 10-Q Crinetics Pharmaceutical For: Mar 31
Form 8-K Crinetics Pharmaceutical For: May 09
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.